Microgynon
Sponsors
Bayer, Eli Lilly and Company, The University of Hong Kong, Boehringer Ingelheim, GlaxoSmithKline
Conditions
Carcinoma, Non-Small-Cell LungClinical Trial ,Phase IContraceptionDrug InteractionsEndometriosisHealthy VolunteersLibidoPharmacokinetics
Phase 1
A Study of Baricitinib and Birth Control Pills in Healthy Females
CompletedNCT01896726
Start: 2013-07-31End: 2013-10-31Updated: 2017-06-06
Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women
CompletedNCT02159326
Start: 2014-06-30End: 2015-07-31Updated: 2015-08-14
Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol
CompletedNCT02170038
Start: 2014-06-30End: 2015-03-31Updated: 2016-02-18
Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer
TerminatedNCT02751385
Start: 2016-05-20End: 2017-11-28Updated: 2019-03-14
Drug-drug Interaction Study: Influence of Vilaprisan on Pharmacodynamics (PD) and Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
CompletedNCT03210246
Start: 2017-07-17End: 2019-01-23Updated: 2019-02-28
A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
CompletedNCT03675581
Start: 2018-11-08End: 2019-10-10Updated: 2020-11-09
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
CompletedNCT06354257
Start: 2024-04-05End: 2024-07-01Updated: 2025-08-26